Skip to main content

Pain relief in children

Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Pain management should start when a child is first diagnosed and should continue throughout the illness. Childhood pain is often complex (particularly cancer pain) and ideally a multidisciplinary approach should be used.

While providing analgesia, the underlying cause of the pain should be determined and treated if possible, remembering that the pain of both diagnostic and therapeutic procedures (eg, bone marrow biopsy) may often be worse than that of the disease. Such pain due to procedures should be treated appropriately.

Continue reading below

Assessment of children

The initial pain assessment of a child reporting or presenting behavioural signs of pain includes:

  • A detailed pain history including location, duration and characteristics of the pain.

  • Details regarding the impact of the pain on the child's sleep, emotional state, relationships, development and physical function.

  • A physical examination.

  • The diagnosis of the causes.

  • The measurement of pain severity using an age-appropriate pain measurement tool.

  • Information regarding treatments already tried.


  • Sucrose, glucose or other sweet solutions have been all shown to reduce pain responses during commonly performed painful procedures in diverse populations of infants up to 12 months of age1.

  • Sucrose has been shown to be safe and effective for reducing procedural pain from single events2.

  • Although sucrose has been widely recommended for routine use during painful procedures in newborn and young infants, the use of sucrose is still not very common3.

  • If available, breastfeeding or breast milk should be used, rather than placebo, positioning or no intervention, to alleviate procedural pain in neonates undergoing a single painful procedure. Administration of glucose or sucrose has been shown to have similar effectiveness to breastfeeding for reducing pain4.

Continue reading below


The correct use of analgesic medicines will relieve pain in most children with persisting pain due to medical illness, and relies on the following key concepts:

  • Using a two-step strategy.

  • Dosing at regular intervals.

  • Using the appropriate route of administration.

  • Adapting treatment to the individual child.

Mild pain

For children aged under 3 months, paracetamol should be offered.

Children aged over 3 months can be offered both paracetamol and ibuprofen.

Moderate-to-severe pain

When the pain is more severe, an opioid drug may necessary to control the pain. Morphine is the medicine of choice.

It is recommended that medication should be given regularly for persisting pain, rather than on an 'as required basis', unless pain episodes are truly intermittent and unpredictable. Children should, therefore, receive analgesics at regular intervals, with the addition of 'rescue doses' for intermittent and breakthrough pain.



  • Sugar-free preparation is appropriate for many children with mild-to-moderate pain.

  • It does not cause respiratory depression but overdose is dangerous, as it may cause hepatic damage and not be apparent for 4-6 days.

  • The dosing for liquid paracetamol products for children was revised in 2011 to one that is based on narrower age bands with a single dosing option per band5.

  • The current recommended oral paracetamol doses are6:

    • Neonate 28 weeks to 32 weeks corrected gestational age: 20 mg/kg for 1 dose, then 10-15 mg/kg every 8-12 hours as required, maximum daily dose to be given in divided doses; maximum 30 mg/kg per day.

    • Neonate 32 weeks corrected gestational age and above: 20 mg/kg for 1 dose, then 10-15 mg/kg every 6-8 hours as required, maximum daily dose to be given in divided doses; maximum 60 mg/kg per day.

    • Age 1-2 months: 30-60 mg every 8 hours as required, maximum daily dose to be given in divided doses; maximum 60 mg/kg per day.

    • Age 3-5 months: 60 mg every 4-6 hours; maximum 4 doses per day.

    • Age 6-23 months: 120 mg every 4-6 hours; maximum 4 doses per day.

    • Age 2-3 years: 180 mg every 4-6 hours; maximum 4 doses per day.

    • Age 4-5 years: 240 mg every 4-6 hours; maximum 4 doses per day.

    • Age 6-7 years: 240-250 mg every 4-6 hours; maximum 4 doses per day.

    • Age 8-9 years: 360-375 mg every 4-6 hours; maximum 4 doses per day.

    • Age 10-11 years: 480-500 mg every 4-6 hours; maximum 4 doses per day.

    • Age 12-15 years: 480-750 mg every 4-6 hours; maximum 4 doses per day.

    • Age 16-17 years: 0.5-1 g every 4-6 hours; maximum 4 doses per day.

Non-steroidal anti-inflammatory drugs (NSAIDs)

  • These are particularly useful where pain is associated with fever (especially in children over the age of 5 years), dental pain and for control of pain in long-term inflammatory conditions.

  • They do, however, cause more gastric irritation than paracetamol and for mild-to-moderate pain, paracetamol is often preferred.

  • Warn asthmatic patients/parents taking NSAIDs for the first time to watch for worsening of bronchospasm.

  • Avoid aspirin in children aged under 16 years, due to risk of Reye's syndrome.

  • The current recommended immediate-release oral ibuprofen doses are6:

    • Age 1-2 months: 5 mg/kg 3-4 times a day.

    • Age 3-5 months: 50 mg 3 times a day, maximum daily dose to be given in 3-4 divided doses; maximum 30 mg/kg per day.

    • Age 6-11 months: 50 mg 3-4 times a day, maximum daily dose to be given in 3-4 divided doses; maximum 30 mg/kg per day.

    • Age 1-3 years: 100 mg 3 times a day, maximum daily dose to be given in 3-4 divided doses; maximum 30 mg/kg per day.

    • Age 4-6 years: 150 mg 3 times a day, maximum daily dose to be given in 3-4 divided doses; maximum 30 mg/kg per day.

    • Age 7-9 years: 200 mg 3 times a day, maximum daily dose to be given in 3-4 divided doses; maximum 30 mg/kg per day; maximum 2.4 g per day.

    • Age 10-11 years: 300 mg 3 times a day, maximum daily dose to be given in 3-4 divided doses; maximum 30 mg/kg per day; maximum 2.4 g per day.

    • Age 12-17 years: initially 300-400 mg 3-4 times a day; increased if necessary up to 600 mg 4 times a day; maintenance 200-400 mg 3 times a day, may be adequate..


  • Morphine is recommended as the first-line strong opioid for the treatment of persisting moderate-to-severe pain in children with medical illnesses.

  • As when prescribing for adults, immediate-release tablets are recommended for titrating morphine dosage and also for defining the adequate dose for pain control. They should also be given for episodic or breakthrough pain.

  • The oral route is usually preferable in children. Palatability, availability of oral solutions, size of tablets and frequency of dosing are important factors to consider.

  • In some children alternative opioids may be given. However, switching opioids should only be considered when the administered medicine has been adequately titrated but the analgesic response is inadequate and side-effects experienced by the child are intolerable.

  • There is insufficient evidence to recommend any alternative opioid in preference to morphine as the opioid of first choice.

  • Fentanyl, hydromorphone, methadone and oxycodone formulations have been considered alternatives to morphine for switching in children with persisting pain.

  • Intranasal fentanyl is being used in some countries, as it has been shown to be safe and also equally effective as intravenous morphine in paediatric patients with moderate-to-severe acute pain78.

  • However, in the UK fentanyl is currently licensed for usage for paediatric pain via the intravenous route but not via the intranasal route6.

  • The main side-effects of opioids as a class are nausea, vomiting, constipation, and drowsiness. Respiratory depression and hypotension occur in larger doses. Neonates, particularly if preterm, may be more susceptible.

  • As long-term opioid use is usually associated with constipation, patients should also receive a combination of a stimulant laxative and a stool softener prophylactically.

  • Doses may need to be adjusted individually according to the degree of analgesia and side-effects.

  • Opioid doses should be calculated and checked with care.

Other medications

  • Pain associated with acute problems of the oral mucosa (eg, acute herpetic gingivostomatitis, erythema multiforme) are sometimes given benzydamine or topical anaesthetics until resolution, in addition to paracetamol or ibuprofen.

  • However, there is actually little evidence for topical lidocaine's efficacy as an analgesic and in aiding oral intake in children with painful infectious mouth conditions9.

  • A recent study has shown that topical lidocaine is actually no more effective than a flavored gel placebo in improving oral intake in children with painful infectious mouth ulcers10.

  • Inhaled nitrous oxide provides useful short-term analgesia for patients undergoing painful procedures and for those who have needle phobia11.

  • EMLA® cream may be used to reduce the pain of venepuncture and has also been successfully used to reduce pain post-circumcision12.

Controlling pain in palliative care13

Whilst the same principles apply to the palliative control of pain in children as for any other condition, additional considerations apply. Care should be comprehensive and address psychological, cultural and spiritual needs. If so desired, this care should be provided at home. Remember factors such as the physical environment, attitudes and behaviours can profoundly increase or decrease children's pain. Pain management therefore relies not only on the use of pain-relieving drugs but also on practical cognitive, behavioural, physical and supportive therapies (many of these therapies can be provided by family members).

  • Paracetamol or an NSAID given regularly will often make the use of opioids unnecessary.

  • NSAIDs are also useful in controlling bone secondaries.

  • Treatment of bone cancer pain usually requires a multidisciplinary approach, such as an orthopaedic intervention, palliative radiotherapy alongside disease-modifying treatment (chemotherapy) and supportive care (analgesic and integrative therapies).

  • When reducing or stopping opioids, doses should be tapered gradually to avoid causing severe pain flare or withdrawal symptoms.

  • Morphine is given by mouth as an oral solution or as standard (immediate-release') tablets regularly every four hours, the initial dose depending largely on the patient's previous treatment. Increase the next dose by 50% if the previous dose was no more effective than the preceding analgesic. Choose the lowest dose which prevents pain and consider adjuvant analgesics (eg, NSAIDs). Titrate stepwise depending on response. Omit an overnight dose if double the usual dose is given at bedtime.

  • Consider rescue doses for breakthrough pain and prophylactic doses 30 minutes before a potentially painful procedure (eg, dressing changes). Use oral morphine solution or standard tablets, about one sixth of the total daily dose every four hours.

  • Side-effects of opioids (eg, constipation) should be anticipated, aggressively treated and regularly reassessed.

  • Once the daily requirement is established, give the total dose od or bd. If required, increase the strength of the dose, not the frequency of administration.

  • Situations when the enteral route is not suitable and an alternative route (eg, subcutaneous, rectal or transdermal) should be sought include:

    • Pain crisis requiring rapid titration of intravenous opioids.

    • Poor absorption: vomiting, disordered gastrointestinal motility.

    • Inability to comply: unconscious; severe nausea, poor swallow; risk of aspiration, medication refusal.

  • Gastrointestinal pain - bowel colic pain may be reduced by loperamide or hyoscine hydrobromide sublingually. Subcutaneous hyoscine can be given via a syringe driver.

  • Muscle spasm - antispasmodic agents, such as baclofen and dantrolene, can be useful although they can cause sedation and hypersalivation. Targeted treatments such as botulinum toxin, surgical intervention and intrathecal drug delivery are becoming more common.

  • Neuropathic pain - a combination of integrative, rehabilitative and supportive treatments with medications such as NSAIDs, opioids, low-dose tricyclics and gabapentinoids are often given14. However, there are very few trials regarding the management of neuropathic pain in children with cancer.

  • Nerve compression may be reduced by a corticosteroid such as dexamethasone, which reduces oedema around the tumour, thus reducing compression.

Although children's understanding of death may vary at different times in their development, they often know when they are dying; their major concerns are frequently fear of abandonment and fear of suffering. It is important to emphasise to such children that they will be kept comfortable and that the people they love will always be with them.

Further reading and references

  1. Harrison D, Beggs S, Stevens B; Sucrose for procedural pain management in infants. Pediatrics. 2012 Nov;130(5):918-25. doi: 10.1542/peds.2011-3848. Epub 2012 Oct 8.
  2. Stevens B, Yamada J, Ohlsson A, et al; Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev. 2016 Jul 16;7:CD001069. doi: 10.1002/14651858.CD001069.pub5.
  3. Pasek TA, Huber JM; Hospitalized infants who hurt: a sweet solution with oral sucrose. Crit Care Nurse. 2012 Feb;32(1):61-9. doi: 10.4037/ccn2012912.
  4. Shah PS, Herbozo C, Aliwalas LL, et al; Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database Syst Rev. 2012 Dec 12;12:CD004950. doi: 10.1002/14651858.CD004950.pub3.
  5. Paracetamol: updated dosing for children to be introduced; Medicines and Healthcare products Regulatory Agency (MHRA), December 2014
  6. British National Formulary (BNF); NICE Evidence Services (UK access only)
  7. Bendall JC, Simpson PM, Middleton PM; Effectiveness of prehospital morphine, fentanyl, and methoxyflurane in pediatric patients. Prehosp Emerg Care. 2011 Apr-Jun;15(2):158-65. doi: 10.3109/10903127.2010.541980. Epub 2011 Feb 4.
  8. Karlsen AP, Pedersen DM, Trautner S, et al; Safety of Intranasal Fentanyl in the Out-of-Hospital Setting: A Prospective Observational Study. Ann Emerg Med. 2013 Nov 13. pii: S0196-0644(13)01544-8. doi: 10.1016/j.annemergmed.2013.10.025.
  9. Hopper SM, Babl FE, McCarthy M, et al; A double blind, randomised placebo controlled trial of topical 2% viscous lidocaine in improving oral intake in children with painful infectious mouth conditions. BMC Pediatr. 2011 Nov 21;11:106. doi: 10.1186/1471-2431-11-106.
  10. Hopper SM, McCarthy M, Tancharoen C, et al; Topical Lidocaine to Improve Oral Intake in Children With Painful Infectious Mouth Ulcers: A Blinded, Randomized, Placebo-Controlled Trial. Ann Emerg Med. 2014 Mar;63(3):292-9. doi: 10.1016/j.annemergmed.2013.08.022. Epub 2013 Nov 7.
  11. Tobias JD; Applications of nitrous oxide for procedural sedation in the pediatric population. Pediatr Emerg Care. 2013 Feb;29(2):245-65. doi: 10.1097/PEC.0b013e318280d824.
  12. Mujeeb S, Akhtar J, Ahmed S; Comparison of eutectic mixture of local anesthetics cream with dorsal penile nerve block using lignocaine for circumcision in infants. Pak J Med Sci. 2013 Jan;29(1):27-30. doi: 10.12669/pjms.291.2944.
  13. Basic Symptom Control in Paediatric Palliative Care; Together for Short Lives, 2013
  14. Friedrichsdorf SJ, Nugent AP; Management of neuropathic pain in children with cancer. Curr Opin Support Palliat Care. 2013 Jun;7(2):131-8. doi: 10.1097/SPC.0b013e3283615ebe.

Article history

The information on this page is written and peer reviewed by qualified clinicians.

symptom checker

Feeling unwell?

Assess your symptoms online for free